<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font7" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font8" size="9" family="SymbolMT" color="#000000"/>
	<fontspec id="font9" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font10" size="8" family="AkzidenzGroteskBE" color="#ffffff"/>
<text top="42" left="56" width="88" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><b>Breast Cancer Research</b></text>
<text top="42" left="144" width="94" height="7" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title">    Vol 8 No 5    Grigoriadis </text>
<text top="42" left="238" width="16" height="7" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><i>et al.</i></text>
<text top="758" left="56" width="45" height="7" font="font1" id="p1_t4" reading_order_no="90" segment_no="10" tag_type="text">Page 4 of 15</text>
<text top="768" left="56" width="120" height="6" font="font3" id="p1_t5" reading_order_no="91" segment_no="11" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="379" left="56" width="84" height="8" font="font4" id="p1_t6" reading_order_no="14" segment_no="3" tag_type="title"><b>Microarray analysis</b></text>
<text top="391" left="56" width="240" height="9" font="font5" id="p1_t7" reading_order_no="15" segment_no="5" tag_type="text">The same total RNA pools were hybridised onto a 20 k cDNA</text>
<text top="402" left="56" width="240" height="9" font="font5" id="p1_t8" reading_order_no="16" segment_no="5" tag_type="text">microarray (20 k brk, constructed at The Breakthrough Breast</text>
<text top="414" left="56" width="240" height="9" font="font5" id="p1_t9" reading_order_no="17" segment_no="5" tag_type="text">Cancer Research Centre, Institute of Cancer Research, Lon-</text>
<text top="426" left="56" width="240" height="9" font="font5" id="p1_t10" reading_order_no="18" segment_no="5" tag_type="text">don, UK containing 19,391 sequence-validated IMAGE</text>
<text top="438" left="56" width="240" height="9" font="font5" id="p1_t11" reading_order_no="19" segment_no="5" tag_type="text">clones), Affymetrix Human Genome U133 Plus 2.0 GeneChip</text>
<text top="449" left="56" width="240" height="9" font="font5" id="p1_t12" reading_order_no="20" segment_no="5" tag_type="text">(Affymetrix, Inc., Santa Clara, CA, USA), CodeLink™ Human</text>
<text top="461" left="56" width="240" height="9" font="font5" id="p1_t13" reading_order_no="21" segment_no="5" tag_type="text">Whole Genome Bioarray (GE, Healthcare, formerly Amersham</text>
<text top="473" left="56" width="240" height="9" font="font5" id="p1_t14" reading_order_no="22" segment_no="5" tag_type="text">Biosciences, Chandler, AZ, USA) and Agilent Whole Human</text>
<text top="485" left="56" width="240" height="9" font="font5" id="p1_t15" reading_order_no="23" segment_no="5" tag_type="text">Genome Oligo Microarray 44 k cDNA array (Agilent Technol-</text>
<text top="496" left="56" width="240" height="9" font="font5" id="p1_t16" reading_order_no="24" segment_no="5" tag_type="text">ogies, Palo Alto, CA, USA). Three technical replicates of each</text>
<text top="508" left="56" width="240" height="9" font="font5" id="p1_t17" reading_order_no="25" segment_no="5" tag_type="text">RNA pool were amplified, labelled and hybridised according to</text>
<text top="520" left="56" width="241" height="9" font="font5" id="p1_t18" reading_order_no="26" segment_no="5" tag_type="text">manufacturer's guidelines. Where necessary an RNA pool</text>
<text top="532" left="56" width="240" height="9" font="font5" id="p1_t19" reading_order_no="27" segment_no="5" tag_type="text">consisting of breast cancer cell lines was used as a reference</text>
<text top="543" left="56" width="241" height="9" font="font5" id="p1_t20" reading_order_no="28" segment_no="5" tag_type="text"><a href="">sample [11] and dye-swap</a> hybridisations were performed. All</text>
<text top="555" left="56" width="240" height="9" font="font5" id="p1_t21" reading_order_no="29" segment_no="5" tag_type="text">primary array data are available through ArrayExpre<a href="">ss [20];</a></text>
<text top="567" left="56" width="241" height="9" font="font5" id="p1_t22" reading_order_no="30" segment_no="5" tag_type="text">they comply with MIAME standards, with the accession</text>
<text top="579" left="56" width="241" height="9" font="font5" id="p1_t23" reading_order_no="31" segment_no="5" tag_type="text">number E-TABM-66. Overlay of each microarray platform with</text>
<text top="590" left="56" width="240" height="9" font="font5" id="p1_t24" reading_order_no="32" segment_no="5" tag_type="text">MPSS was done by mapping the sequence information of</text>
<text top="602" left="56" width="240" height="9" font="font5" id="p1_t25" reading_order_no="33" segment_no="5" tag_type="text">probes and probe sets to the same HTR database as used for</text>
<text top="614" left="56" width="240" height="9" font="font5" id="p1_t26" reading_order_no="34" segment_no="5" tag_type="text">MPSS tag mapping (see above). Only those microarray fea-</text>
<text top="626" left="56" width="240" height="9" font="font5" id="p1_t27" reading_order_no="35" segment_no="5" tag_type="text">tures that were unambiguously mapped to a single HTR clus-</text>
<text top="637" left="56" width="240" height="9" font="font5" id="p1_t28" reading_order_no="36" segment_no="5" tag_type="text">ter were included for further studies. All preprocessing of each</text>
<text top="649" left="56" width="240" height="9" font="font5" id="p1_t29" reading_order_no="37" segment_no="5" tag_type="text">microarray platform and further statistical analysis was per-</text>
<text top="661" left="56" width="240" height="9" font="font5" id="p1_t30" reading_order_no="38" segment_no="5" tag_type="text">formed in the R 2.1.1 environmen<a href="">t [24] by making extensiv</a>e</text>
<text top="673" left="56" width="241" height="9" font="font5" id="p1_t31" reading_order_no="39" segment_no="5" tag_type="text">usage of the limma packag<a href="">e [25] in BioConductor 1.6 </a>[<a href="">26]</a>.</text>
<text top="684" left="56" width="240" height="9" font="font5" id="p1_t32" reading_order_no="40" segment_no="5" tag_type="text">For the Affymetrix platform, probe-level data were normalised</text>
<text top="696" left="56" width="240" height="9" font="font5" id="p1_t33" reading_order_no="41" segment_no="5" tag_type="text">and expression data were summarised by the robust multi-</text>
<text top="708" left="56" width="240" height="9" font="font5" id="p1_t34" reading_order_no="42" segment_no="5" tag_type="text">ar<a href="">ray analysis [27]; cyc</a>lic lowess normalisation was applied to</text>
<text top="720" left="56" width="182" height="9" font="font5" id="p1_t35" reading_order_no="43" segment_no="5" tag_type="text">the CodeLink™ expression data through the </text>
<text top="720" left="239" width="36" height="9" font="font6" id="p1_t36" reading_order_no="44" segment_no="5" tag_type="text"><i>codelink </i></text>
<text top="720" left="276" width="20" height="9" font="font5" id="p1_t37" reading_order_no="45" segment_no="5" tag_type="text">0.7.2</text>
<text top="379" left="315" width="240" height="9" font="font5" id="p1_t38" reading_order_no="46" segment_no="4" tag_type="text">package in R 2.3; for the Agilent microarrays, global normali-</text>
<text top="391" left="315" width="240" height="9" font="font5" id="p1_t39" reading_order_no="47" segment_no="4" tag_type="text">sation with no background correction was applied; and for the</text>
<text top="402" left="315" width="240" height="9" font="font5" id="p1_t40" reading_order_no="48" segment_no="4" tag_type="text">20 k brk microarrays, raw expression data were print-tip</text>
<text top="414" left="315" width="240" height="9" font="font5" id="p1_t41" reading_order_no="49" segment_no="4" tag_type="text">normalised and background corrected. Relative measure-</text>
<text top="426" left="315" width="180" height="9" font="font5" id="p1_t42" reading_order_no="50" segment_no="4" tag_type="text">ments for each transcript were given as a log</text>
<text top="430" left="495" width="5" height="6" font="font7" id="p1_t43" reading_order_no="51" segment_no="4" tag_type="text">2 </text>
<text top="426" left="501" width="55" height="9" font="font5" id="p1_t44" reading_order_no="52" segment_no="4" tag_type="text">fold ratio, and</text>
<text top="438" left="315" width="184" height="9" font="font5" id="p1_t45" reading_order_no="53" segment_no="4" tag_type="text">only genes with a false discovery prediction of </text>
<text top="438" left="499" width="9" height="9" font="font6" id="p1_t46" reading_order_no="54" segment_no="4" tag_type="text"><i>P </i></text>
<text top="435" left="507" width="5" height="11" font="font8" id="p1_t47" reading_order_no="55" segment_no="4" tag_type="text">≤</text>
<text top="438" left="512" width="43" height="9" font="font5" id="p1_t48" reading_order_no="56" segment_no="4" tag_type="text"> 0.05 were</text>
<text top="449" left="315" width="240" height="9" font="font5" id="p1_t49" reading_order_no="57" segment_no="4" tag_type="text">regarded as significantly differentially expressed when using</text>
<text top="461" left="315" width="109" height="9" font="font5" id="p1_t50" reading_order_no="58" segment_no="4" tag_type="text">Benjamini and Hochberg' s </text>
<text top="461" left="424" width="9" height="9" font="font6" id="p1_t51" reading_order_no="59" segment_no="4" tag_type="text"><i>P </i></text>
<text top="461" left="432" width="91" height="9" font="font5" id="p1_t52" reading_order_no="60" segment_no="4" tag_type="text">values adjustment [<a href="">28]</a>.</text>
<text top="485" left="315" width="65" height="8" font="font4" id="p1_t53" reading_order_no="61" segment_no="6" tag_type="title"><b>Gene Ontology</b></text>
<text top="496" left="315" width="240" height="9" font="font5" id="p1_t54" reading_order_no="62" segment_no="7" tag_type="text">Genes were categorised with respect to their biological proc-</text>
<text top="508" left="315" width="240" height="9" font="font5" id="p1_t55" reading_order_no="63" segment_no="7" tag_type="text">ess, cellular role, molecular function, using Onto-Express (OE)</text>
<text top="520" left="315" width="241" height="9" font="font5" id="p1_t56" reading_order_no="64" segment_no="7" tag_type="text"><a href="">[29,30]. The </a>most significant perturbed biological processes</text>
<text top="532" left="315" width="240" height="9" font="font5" id="p1_t57" reading_order_no="65" segment_no="7" tag_type="text">were determined with respect to the number of genes</text>
<text top="543" left="315" width="240" height="9" font="font5" id="p1_t58" reading_order_no="66" segment_no="7" tag_type="text">expected for each Gene Ontology (GO) category based on</text>
<text top="555" left="315" width="240" height="9" font="font5" id="p1_t59" reading_order_no="67" segment_no="7" tag_type="text">their representation on the Affymetrix U133 Plus 2.0 array.</text>
<text top="567" left="315" width="240" height="9" font="font5" id="p1_t60" reading_order_no="68" segment_no="7" tag_type="text">Statistical significance was determined by using OE's hyper-</text>
<text top="579" left="315" width="240" height="9" font="font5" id="p1_t61" reading_order_no="69" segment_no="7" tag_type="text">geometric probability distribution and Bonferroni correction</text>
<text top="590" left="315" width="117" height="9" font="font5" id="p1_t62" reading_order_no="70" segment_no="7" tag_type="text">options, and annotations with </text>
<text top="590" left="432" width="9" height="9" font="font6" id="p1_t63" reading_order_no="71" segment_no="7" tag_type="text"><i>P </i></text>
<text top="588" left="440" width="5" height="11" font="font8" id="p1_t64" reading_order_no="72" segment_no="7" tag_type="text">≤</text>
<text top="590" left="445" width="110" height="9" font="font5" id="p1_t65" reading_order_no="73" segment_no="7" tag_type="text"> 0.05 were accepted as sig-</text>
<text top="602" left="315" width="240" height="9" font="font5" id="p1_t66" reading_order_no="74" segment_no="7" tag_type="text">nificant. Gene set enrichment analysis (GSEA) comparing</text>
<text top="614" left="315" width="240" height="9" font="font5" id="p1_t67" reading_order_no="75" segment_no="7" tag_type="text">luminal and myoepithelial gene signatures was done using</text>
<text top="626" left="315" width="240" height="9" font="font5" id="p1_t68" reading_order_no="76" segment_no="7" tag_type="text">described method<a href="">s [31]. Biolo</a>gical processes were ranked</text>
<text top="637" left="315" width="241" height="9" font="font5" id="p1_t69" reading_order_no="77" segment_no="7" tag_type="text">according to their significance of enrichment, and the valida-</text>
<text top="649" left="315" width="240" height="9" font="font5" id="p1_t70" reading_order_no="78" segment_no="7" tag_type="text">tion mode measure of significance was used to identify those</text>
<text top="661" left="315" width="90" height="9" font="font5" id="p1_t71" reading_order_no="79" segment_no="7" tag_type="text">of greatest enrichment.</text>
<text top="684" left="315" width="109" height="8" font="font4" id="p1_t72" reading_order_no="80" segment_no="8" tag_type="title"><b>Semiquantitative RT-PCR</b></text>
<text top="696" left="315" width="61" height="9" font="font5" id="p1_t73" reading_order_no="81" segment_no="9" tag_type="text">Total RNA (10 </text>
<text top="693" left="375" width="5" height="11" font="font8" id="p1_t74" reading_order_no="82" segment_no="9" tag_type="text">µ</text>
<text top="696" left="381" width="174" height="9" font="font5" id="p1_t75" reading_order_no="83" segment_no="9" tag_type="text">g) from the normal luminal epithelial and the</text>
<text top="708" left="315" width="233" height="9" font="font5" id="p1_t76" reading_order_no="84" segment_no="9" tag_type="text">malignant epithelial RNA pool was used for each 40 </text>
<text top="705" left="548" width="5" height="11" font="font8" id="p1_t77" reading_order_no="85" segment_no="9" tag_type="text">µ</text>
<text top="708" left="553" width="2" height="9" font="font5" id="p1_t78" reading_order_no="86" segment_no="9" tag_type="text">l</text>
<text top="720" left="315" width="148" height="9" font="font5" id="p1_t79" reading_order_no="87" segment_no="9" tag_type="text">reverse-transcription reaction, and 10 </text>
<text top="717" left="462" width="5" height="11" font="font8" id="p1_t80" reading_order_no="88" segment_no="9" tag_type="text">µ</text>
<text top="720" left="468" width="88" height="9" font="font5" id="p1_t81" reading_order_no="89" segment_no="9" tag_type="text">l of 1/50 diluted cDNA</text>
<text top="85" left="56" width="31" height="7" font="font9" id="p1_t82" reading_order_no="3" segment_no="1" tag_type="title"><b>Figure 1</b></text>
<text top="291" left="56" width="315" height="7" font="font10" id="p1_t83" reading_order_no="4" segment_no="2" tag_type="text">Comparison of massively parallel signature sequencing (MPSS) data with microarray analysis</text>
<text top="291" left="56" width="487" height="7" font="font1" id="p1_t84" reading_order_no="5" segment_no="2" tag_type="text">Comparison of massively parallel signature sequencing (MPSS) data with microarray analysis. Differentially expressed gene profiles from MPSS </text>
<text top="300" left="56" width="218" height="7" font="font1" id="p1_t85" reading_order_no="6" segment_no="2" tag_type="text">(100%) were overlaid with each microarray platform individually. </text>
<text top="300" left="275" width="12" height="7" font="font0" id="p1_t86" reading_order_no="7" segment_no="2" tag_type="text"><b>(a) </b></text>
<text top="300" left="287" width="267" height="7" font="font1" id="p1_t87" reading_order_no="8" segment_no="2" tag_type="text">Percentage of coverage (light grey) and concordance in differential expression </text>
<text top="310" left="56" width="499" height="7" font="font1" id="p1_t88" reading_order_no="9" segment_no="2" tag_type="text">between MPSS and individual arrays (dark grey) are shown together with the combined coverage and confirmation by at least one array (1 platform). </text>
<text top="319" left="56" width="12" height="7" font="font0" id="p1_t89" reading_order_no="10" segment_no="2" tag_type="text"><b>(b) </b></text>
<text top="319" left="69" width="485" height="7" font="font1" id="p1_t90" reading_order_no="11" segment_no="2" tag_type="text">Enumeration of the differentially expressed transcripts detected by "MPSS-only", by "MPSS and array", and those transcripts reported as differ-</text>
<text top="329" left="56" width="499" height="7" font="font1" id="p1_t91" reading_order_no="12" segment_no="2" tag_type="text">ential by at least two arrays, but not by MPSS ("Array only"). The results obtained by RT-PCR for these subgroups are shown below (see Additional </text>
<text top="338" left="56" width="21" height="7" font="font1" id="p1_t92" reading_order_no="13" segment_no="2" tag_type="text">file 6).</text>
</page>
</pdf2xml>
